Welcome to LookChem.com Sign In|Join Free
  • or
4-(5-BroMo-thiophene-2-sulfonyl)-Morpholine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

81597-64-0

Post Buying Request

81597-64-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

81597-64-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 81597-64-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,5,9 and 7 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 81597-64:
(7*8)+(6*1)+(5*5)+(4*9)+(3*7)+(2*6)+(1*4)=160
160 % 10 = 0
So 81597-64-0 is a valid CAS Registry Number.

81597-64-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[(5-Bromo-2-thienyl)sulfonyl]morpholine

1.2 Other means of identification

Product number -
Other names 5-bromo-2-thiopheneglyoxylaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:81597-64-0 SDS

81597-64-0Downstream Products

81597-64-0Relevant academic research and scientific papers

BENZIMIDAZOLE CANNABINOID AGONISTS BEARING A SUBSTITUTED HETEROCYCLIC GROUP

-

Paragraph 0172; 0173, (2014/01/07)

The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.

BENZIMIDAZOLE CANNABINOID AGONISTS BEARING A SUBSTITUTED HETEROCYCLIC GROUP

-

Page/Page column 30, (2008/06/13)

The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 81597-64-0